October 29, 2020 09:00 - 10:15 EDT
Life sciences have taken on increased importance in recent months, and are sure to be a significant part of Canada’s post-pandemic economy. Join us for our five-part webinar series that will discuss the latest legal and regulatory developments at all stages of the sector’s complex life cycle.
COVID-19 may have disrupted IP litigation in 2020, but the year has still seen high-impact developments affecting life sciences companies. Our IP regulatory and litigation team Andy Shaughnessy, Eileen McMahon, Karen Townsend and Alexandra Peterson will review the latest developments—including data protection, patent term extension and strategies, as well as important decisions on substantive patent law—all of which may affect life sciences innovation and business models going forward.
9:00 a.m. EDT Webinar opens
9:15 - 10:15 a.m. EDT Presentation
Ontario: This program is eligible for up to 1.0 Substantive hour.
New York: This program contains 1.0 Areas of Professional Practice Credit.
Sessions in this series: